Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
Go back to Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial| (NASDAQ: CMND) | Delayed: 1.91 -0.05 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $ | |||
| Open | $1.96 | 52 Week Low | $ | |||
| Day High | $1.96 | P/E | N/A | |||
| Day Low | $1.88 | EPS | $ | |||
| Volume | 63,442 | |||||
